“novartis” Archives

Entry Author Date Location
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD 10/13/16 Boston
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Elanco Reaches $885M Deal for Boehringer’s Pet Vaccines Portfolio 10/05/16 Indiana
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue 10/03/16 Boston
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Caribou CEO Touts Incubator’s Role Translating Science into Startup 09/29/16 Texas
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
With $163M Deal, Tarveda Revives Synta Pharma’s Cancer Drug Work 09/19/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
Harvard Unveils $15M Life Lab to House Biotech and Medical Startups 06/08/16 Boston
Bankrupt Biotech KineMed Owes More Than $1M To Gates, Others 05/13/16 San Francisco
G1 Therapeutics Hauls in $47M for Lung, Breast Cancer Trials 05/12/16 Raleigh Durham
Ariad Sells Off Europe Hub, Drug Rights in $140M Incyte Deal 05/09/16 Boston
CRISPR Drug Maker Intellia Therapeutics Sells $108M In IPO Shares 05/05/16 Boston
Page 1 of 18 next page »